INSTANT INSIGHT: Massive Corporate Buybacks, BOJ Firepower & PBoC Central Planning

Takeaway: Corporate Buybacks; U.S. #GrowthSlowing; The Lone BOJ Dissenter; PBoC Central Planning

INSTANT INSIGHT: Massive Corporate Buybacks, BOJ Firepower & PBoC Central Planning - earth

 

Below are a collection of interesting links and insights from today's news with analysis filtered through the Hedgeye macro lens. This installment discusses a recent record for corporate buybacks, U.S. #GrowthSlowing via Bed Bath & Beyond, BOJ central planning and China's yuan policy and shadow stimulus.

 

Enjoy! 

 

The 2nd-Largest Quarter Of Corp Buybacks Ever

"Companies in the S&P 500 spent $161.4 billion buying back shares in the first quarter of 2016, the second-largest amount on record, supporting stock prices amid the index’s early-year drop," the Wall Street Journal reports. Why are companies buying back shares? Simple. "As Earnings Slow, companies lever up and buy back stock to hit EPS targets that determine executive bonuses," Hedgeye CEO Keith McCullough writes.

 

Another U.S. #GrowthSlowing Casualty

"In other news, Bed Bath & Beyond (BBBY) is the latest US #ConsumerSlowing report (post market close)," McCullough wrote. BBBY posted a sales decline and missed earnings estimates as foot traffic slowed and increasing competition from Amazon.com hurt results. 

 

The Lone BOJ Dissenter Rips On Negative Rates

"The additional (positive) effects of quantitative and qualitative easing have been diminishing," Takahide Kiuchi told business leaders at a conference today. "On the other hand, numerous side effects of QQE seem to be increasing steadily," he said. Kiuchi has said before that the BOJ's sustained ultra-low interest rates and the negative rates decision had destabilizing effects on the bond market and hurt the central bank's credibility.

 

In other Japan-related Central Planning News

Is the BOJ holding back its bond buying firepower for after today's Brexit vote? Maybe. Bloomberg reports:

 

"Up to now, the Bank of Japan has tended to conduct bond-purchase operations -- known locally as “rinban” -- on the days following a government auction. Not this time. The Finance Ministry had sold about 400 billion yen ($3.8 billion) of Japanese government bonds with tenors of 20, 30 and 40 years on Friday, but come Monday, the central bank wasn’t buying.”

 

With yields on Japanese government bonds touching record lows last week, perhaps the BOJ is just holding off and letting the market ride for a bit? 

 

China, Yuan & Shadow Stimulus

According to China's state-owned media outlet Xinhua, the People's Bank of China is making strides toward "increas[ing] the investability of the renminbi." A seperate Xinhua article this week explains:

 

"The central bank has stressed that it will stick to market-oriented reforms and increase the yuan's exchange rate flexibility, according to the commentary 'Understand the yuan's fluctuations.'

 

'What needs to be avoided is not fluctuations but possible risks caused by them,' said the article, adding that while risks do exist, there is no basis for long-term depreciation of the yuan.

 

'We should make sound plans to respond to any risks, rather than hesitating over risk concerns,' it read."

 

Another interesting read on China, check out the FT's piece "China deploys state enterprises to economic stimulus effort." Here's the key takeaway from the chart below. Essentially, China's state-owned entities are doing the government's bidding to stimulate its slowing economy.

 

INSTANT INSIGHT: Massive Corporate Buybacks, BOJ Firepower & PBoC Central Planning - china investment

 


Cartoon of the Day: Crash Test Bear

In the past six months, U.S. stock indices are up between +12% and +18%.

read more

GOLD: A Deep Dive on What’s Next with a Top Commodities Strategist

“If you saved in gold over the past 20 to 25 years rather than any currency anywhere in the world, gold has outperformed all these currencies,” says Stefan Wieler, Vice President of Goldmoney in this edition of Real Conversations.

read more

Exact Sciences Up +24% This Week... What's Next? | $EXAS

We remain long Exact Sciences in the Hedgeye Healthcare Position Monitor.

read more

Inside the Atlanta Fed's Flawed GDP Tracker

"The Atlanta Fed’s GDPNowcast model, while useful at amalgamating investor consensus on one singular GDP estimate for any given quarter, is certainly not the end-all-be-all of forecasting U.S. GDP," writes Hedgeye Senior Macro analyst Darius Dale.

read more

Cartoon of the Day: Acrophobia

"Most people who are making a ton of money right now are focused on growth companies seeing accelerations," Hedgeye CEO Keith McCullough wrote in today's Early Look. "That’s what happens in Quad 1."

read more

People's Bank of China Spins China’s Bad-Loan Data

PBoC Deputy Governor Yi says China's non-performing loan problem has “pretty much stabilized." "Yi is spinning. China’s bad-debt problem remains serious," write Benn Steil and Emma Smith, Council on Foreign Relations.

read more

UnderArmour: 'I Am Much More Bearish Than I Was 3 Hours Ago'

“The consumer has a short memory.” Yes, Plank actually said this," writes Hedgeye Retail analyst Brian McGough. "Last time I heard such arrogance was Ron Johnson."

read more

Buffalo Wild Wings: Complacency & Lack of Leadership (by Howard Penney)

"Buffalo Wild Wings has been plagued by complacency and a continued lack of adequate leadership," writes Hedgeye Restaurants analyst Howard Penney.

read more

Todd Jordan on Las Vegas Sands Earnings

"The quarter actually beat lowered expectations. Overall, the mass segment performed well although base mass lagging is a concern," writes Hedgeye Gaming, Lodging & Leisure analyst Todd Jordan on Las Vegas Sands.

read more

An Update on Defense Spending by Lt. Gen Emo Gardner

"Congress' FY17 omnibus appropriation will fully fund the Pentagon's original budget request plus $15B of its $30B supplemental request," writes Hedgeye Potomac Defense Policy analyst Lt. Gen Emerson "Emo" Gardner USMC Ret.

read more

Got Process? Zero Hedge Sells Fear, Not Truth

Fear sells. Always has. Look no further than Zero Hedge.

read more

REPLAY: Review of $EXAS Earnings Call (A Hedgeye Best Idea Long)

Our Healthcare Team made a monster call to be long EXAS - hear their updated thoughts.

read more